Literature DB >> 21084167

Host expression of methylmalonyl-CoA mutase and tuberculosis: a missing link?

José de la Fuente1, Christian Gortazar, Joaquín Vicente, Margarita Villar.   

Abstract

Bovine tuberculosis (bTB) is a disease caused by Mycobacterium bovis and closely related species of the Mycobacterium tuberculosis complex. bTB is an important health problem affecting livestock, wild animals and accounting for up to 10% of human TB cases worldwide. Several hypotheses have been considered to explain the low incidence of active TB despite high infection rates and the variable response to BCG vaccination. These hypotheses have considered genetic factors of immunized individuals and BCG strains, sensitization to environmental mycobacteria and metabolic processes. However, a link has not been established between genetic factors and metabolic processes that may affect the outcome of M. bovis infection and response to BCG vaccination. Herein we used published data linking host cholesterol metabolism with mycobacterial infection, persistence and disease outcome, and results obtained from studies of M. bovis infection and BCG vaccination in the wild boar bTB model to propose a hypothesis: host genetically-defined higher host methylmalonyl-CoA mutase (MUT) expression levels result in lower serum cholesterol concentration and tissue deposits that increase the protective immune response to M. bovis, thus resulting in resistance to bTB and better response to BCG vaccination. If the hypothesis is proven true, these results have important implications for the prevention and treatment of bTB in humans and for the eradication of bTB in wildlife reservoir hosts.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084167     DOI: 10.1016/j.mehy.2010.10.040

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

1.  Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis.

Authors:  Joseba M Garrido; Iker A Sevilla; Beatriz Beltrán-Beck; Esmeralda Minguijón; Cristina Ballesteros; Ruth C Galindo; Mariana Boadella; Konstantin P Lyashchenko; Beatriz Romero; Maria Victoria Geijo; Francisco Ruiz-Fons; Alicia Aranaz; Ramón A Juste; Joaquín Vicente; José de la Fuente; Christian Gortázar
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

2.  Oral vaccination with heat inactivated Mycobacterium bovis activates the complement system to protect against tuberculosis.

Authors:  Beatriz Beltrán-Beck; José de la Fuente; Joseba M Garrido; Alicia Aranaz; Iker Sevilla; Margarita Villar; Mariana Boadella; Ruth C Galindo; José M Pérez de la Lastra; Juan A Moreno-Cid; Isabel G Fernández de Mera; Pilar Alberdi; Gracia Santos; Cristina Ballesteros; Konstantin P Lyashchenko; Esmeralda Minguijón; Beatriz Romero; Lucía de Juan; Lucas Domínguez; Ramón Juste; Christian Gortazar
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

3.  Progress in Oral Vaccination against Tuberculosis in Its Main Wildlife Reservoir in Iberia, the Eurasian Wild Boar.

Authors:  Beatriz Beltrán-Beck; Cristina Ballesteros; Joaquín Vicente; José de la Fuente; Christian Gortázar
Journal:  Vet Med Int       Date:  2012-07-10

4.  Comparative Genomics of Field Isolates of Mycobacterium bovis and M. caprae Provides Evidence for Possible Correlates with Bacterial Viability and Virulence.

Authors:  José de la Fuente; Iratxe Díez-Delgado; Marinela Contreras; Joaquín Vicente; Alejandro Cabezas-Cruz; Raquel Tobes; Marina Manrique; Vladimir López; Beatriz Romero; Javier Bezos; Lucas Dominguez; Iker A Sevilla; Joseba M Garrido; Ramón Juste; Guillermo Madico; Edward Jones-López; Christian Gortazar
Journal:  PLoS Negl Trop Dis       Date:  2015-11-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.